TRILUMINATE's primary endpoint was a hierarchical composite of death from any cause or tricuspid valve surgery, ...

At two years of follow-up, patients with a poorly functioning tricuspid valve in the heart who received the best available ...

The recommendations are similar to those recently announced for TTVR, with the final NCD for T-TEER expected by July.

The TRILUMINATE Pivotal trial was designed to determine whether patients at intermediate or greater risk for complications from tricuspid valve surgery would benefit from medical therapy plus TEER ...

Background Cardiac surgery carries a heightened risk of bradyarrhythmias, but current permanent pacemaker (PPM) implantation ...

A team of specialists at Moulay Youssef Hospital Center in Rabat successfully performed Morocco’s first surgical procedure to treat tricuspid valve insufficiency on Tuesday. The complex five ...

Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.

After seeking help at MedStar Union Memorial Hospital, Mertz was diagnosed with the condition and was told she would need a tricuspid valve replacement. Normally, this type of surgery requires ...

Opens in a new tab or window Based on the finalized national coverage determination (NCD) for transcatheter tricuspid valve replacement, Medicare will cover the procedure when used for an FDA ...

The chordae tendineae (CT), often referred to as the “heart strings,” are thin, tendinous structures that connect the heart ...

Abbott (NYSE: ABT) today announced data demonstrating substantial, sustained improvements with its TriClip system.